| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
35,380,000 |
| Market
Cap: |
35.38(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1 - $1.25 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
141,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$49,703 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
114 |
114 |
114 |
| Total Sell Value |
$0 |
$10 |
$10 |
$10 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
2 |
2 |
2 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nohra Guy P |
10% Owner |
– – • |
2014-11-25 |
4/A |
OE |
$8.54 |
$799,993 |
I/I |
93,676 |
2,595,257 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
D |
$14.00 |
$37,562 |
D/D |
(2,683) |
48,023 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
OE |
$8.54 |
$37,550 |
D/D |
4,397 |
49,748 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
46,309 |
46,309 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
B |
$14.00 |
$980,000 |
D/D |
70,000 |
3,091,642 |
2.45 |
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
D |
$14.00 |
$2,202,438 |
D/D |
(157,317) |
3,021,642 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
OE |
$8.54 |
$2,202,423 |
D/D |
257,895 |
3,122,774 |
|
- |
|
| Halak Brian K |
10% Owner |
– – • |
2014-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,921,064 |
2,921,064 |
|
- |
|
| Rusnanomedinvest Llc |
10% Owner |
– – • |
2014-11-25 |
4 |
B |
$14.00 |
$980,000 |
D/D |
70,000 |
1,585,549 |
2.45 |
- |
|
| Rusnanomedinvest Llc |
10% Owner |
– – • |
2014-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,515,549 |
1,515,549 |
|
- |
|
| Gorbachev Maxim |
Director |
– • • |
2014-11-25 |
4 |
B |
$14.00 |
$980,000 |
I/I |
70,000 |
1,585,549 |
2.25 |
- |
|
| Gorbachev Maxim |
Director |
– • • |
2014-11-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,515,549 |
1,515,549 |
|
- |
|
| Nohra Guy P |
10% Owner |
– – • |
2014-11-25 |
4 |
B |
$14.00 |
$980,000 |
I/I |
70,000 |
2,667,024 |
1.5 |
- |
|
| Nohra Guy P |
10% Owner |
– – • |
2014-11-25 |
4 |
S |
$14.00 |
$2,090,004 |
I/I |
(149,286) |
2,597,024 |
|
- |
|
| Nohra Guy P |
10% Owner |
– – • |
2014-11-25 |
4 |
OE |
$8.54 |
$2,347,595 |
I/I |
244,729 |
2,618,453 |
|
- |
|
| Nohra Guy P |
10% Owner |
– – • |
2014-11-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,497,647 |
2,501,581 |
|
- |
|
| Alta Partners Viii, L.p. |
10% Owner |
– – • |
2014-11-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,934 |
|
- |
|
| Mahaffey George W |
President and CEOOfficer |
• • – |
2014-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
196,721 |
|
- |
|
| Kamdar Kim P. |
Director |
– • • |
2014-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,934 |
|
- |
|
194 Records found
|
|
Page 8 of 8 |
|
|
